Global and United States Pharmaceutical Contract Manufacturing and Contract Market Size, Status and Forecast 2021-2027

Publisher Name :
Date: 06-Sep-2021
No. of pages: 127
Inquire Before Buying

Contract pharmaceutical manufacturing refers to accept commissioned from pharmaceutical companies, provide the service about API production, agent production, packaging and son on which required for pharmaceutical manufacturing.

North America is the largest consumption place, with a consumption market share nearly 35% in 2018. Following North America, Europe is the second largest consumption place with the consumption market share of 23%.

Market Analysis and Insights: Global Pharmaceutical Contract Manufacturing and Contract Market

The global Pharmaceutical Contract Manufacturing and Contract market size is projected to reach US$ 127440 million by 2027, from US$ 82550 million in 2020, at a CAGR of 6.4% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Pharmaceutical Contract Manufacturing and Contract market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Pharmaceutical Contract Manufacturing and Contract market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Pharmaceutical Contract Manufacturing and Contract market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Pharmaceutical Contract Manufacturing and Contract market.

Global Pharmaceutical Contract Manufacturing and Contract Scope and Market Size

Pharmaceutical Contract Manufacturing and Contract market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Pharmaceutical Contract Manufacturing and Contract market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type

- Oral

- Injectable

- API

- Other

- The proportion of API Manufacturing in 2018 is about 73%, and the proportion is in decreasing trend from 2014 to 2018. However, the Injectable segment is the fastest growing segment.

Segment by Application

- Small Medium Enterprise

- Large Enterprise

- The most proportion of pharmaceutical contract manufacturing & contract is used for Large Enterprise, and the proportion in 2018 is 60%.

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

By Company

- Catalent

- Thermo Fisher Scientific

- Lonza

- Boehringer Ingelheim

- Fareva

- Recipharm

- Aenova

- AbbVie

- Baxter

- Nipro Corp

- Sopharma

- Famar

- Vetter

- Shandong Xinhua

- Piramal

- Mylan

- Dr. Reddy's

- Zhejiang Hisun

- Zhejiang Huahai

- Jubilant

Global and United States Pharmaceutical Contract Manufacturing and Contract Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmaceutical Contract Manufacturing and Contract Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Oral
1.2.3 Injectable
1.2.4 API
1.2.5 Other
1.3 Market by Application
1.3.1 Global Pharmaceutical Contract Manufacturing and Contract Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Small Medium Enterprise
1.3.3 Large Enterprise
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Pharmaceutical Contract Manufacturing and Contract Market Perspective (2016-2027)
2.2 Pharmaceutical Contract Manufacturing and Contract Growth Trends by Regions
2.2.1 Pharmaceutical Contract Manufacturing and Contract Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Pharmaceutical Contract Manufacturing and Contract Historic Market Share by Regions (2016-2021)
2.2.3 Pharmaceutical Contract Manufacturing and Contract Forecasted Market Size by Regions (2022-2027)
2.3 Pharmaceutical Contract Manufacturing and Contract Industry Dynamic
2.3.1 Pharmaceutical Contract Manufacturing and Contract Market Trends
2.3.2 Pharmaceutical Contract Manufacturing and Contract Market Drivers
2.3.3 Pharmaceutical Contract Manufacturing and Contract Market Challenges
2.3.4 Pharmaceutical Contract Manufacturing and Contract Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharmaceutical Contract Manufacturing and Contract Players by Revenue
3.1.1 Global Top Pharmaceutical Contract Manufacturing and Contract Players by Revenue (2016-2021)
3.1.2 Global Pharmaceutical Contract Manufacturing and Contract Revenue Market Share by Players (2016-2021)
3.2 Global Pharmaceutical Contract Manufacturing and Contract Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Pharmaceutical Contract Manufacturing and Contract Revenue
3.4 Global Pharmaceutical Contract Manufacturing and Contract Market Concentration Ratio
3.4.1 Global Pharmaceutical Contract Manufacturing and Contract Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical Contract Manufacturing and Contract Revenue in 2020
3.5 Pharmaceutical Contract Manufacturing and Contract Key Players Head office and Area Served
3.6 Key Players Pharmaceutical Contract Manufacturing and Contract Product Solution and Service
3.7 Date of Enter into Pharmaceutical Contract Manufacturing and Contract Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmaceutical Contract Manufacturing and Contract Breakdown Data by Type
4.1 Global Pharmaceutical Contract Manufacturing and Contract Historic Market Size by Type (2016-2021)
4.2 Global Pharmaceutical Contract Manufacturing and Contract Forecasted Market Size by Type (2022-2027)
5 Pharmaceutical Contract Manufacturing and Contract Breakdown Data by Application
5.1 Global Pharmaceutical Contract Manufacturing and Contract Historic Market Size by Application (2016-2021)
5.2 Global Pharmaceutical Contract Manufacturing and Contract Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Pharmaceutical Contract Manufacturing and Contract Market Size (2016-2027)
6.2 North America Pharmaceutical Contract Manufacturing and Contract Market Size by Type
6.2.1 North America Pharmaceutical Contract Manufacturing and Contract Market Size by Type (2016-2021)
6.2.2 North America Pharmaceutical Contract Manufacturing and Contract Market Size by Type (2022-2027)
6.2.3 North America Pharmaceutical Contract Manufacturing and Contract Market Size by Type (2016-2027)
6.3 North America Pharmaceutical Contract Manufacturing and Contract Market Size by Application
6.3.1 North America Pharmaceutical Contract Manufacturing and Contract Market Size by Application (2016-2021)
6.3.2 North America Pharmaceutical Contract Manufacturing and Contract Market Size by Application (2022-2027)
6.3.3 North America Pharmaceutical Contract Manufacturing and Contract Market Size by Application (2016-2027)
6.4 North America Pharmaceutical Contract Manufacturing and Contract Market Size by Country
6.4.1 North America Pharmaceutical Contract Manufacturing and Contract Market Size by Country (2016-2021)
6.4.2 North America Pharmaceutical Contract Manufacturing and Contract Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Pharmaceutical Contract Manufacturing and Contract Market Size (2016-2027)
7.2 Europe Pharmaceutical Contract Manufacturing and Contract Market Size by Type
7.2.1 Europe Pharmaceutical Contract Manufacturing and Contract Market Size by Type (2016-2021)
7.2.2 Europe Pharmaceutical Contract Manufacturing and Contract Market Size by Type (2022-2027)
7.2.3 Europe Pharmaceutical Contract Manufacturing and Contract Market Size by Type (2016-2027)
7.3 Europe Pharmaceutical Contract Manufacturing and Contract Market Size by Application
7.3.1 Europe Pharmaceutical Contract Manufacturing and Contract Market Size by Application (2016-2021)
7.3.2 Europe Pharmaceutical Contract Manufacturing and Contract Market Size by Application (2022-2027)
7.3.3 Europe Pharmaceutical Contract Manufacturing and Contract Market Size by Application (2016-2027)
7.4 Europe Pharmaceutical Contract Manufacturing and Contract Market Size by Country
7.4.1 Europe Pharmaceutical Contract Manufacturing and Contract Market Size by Country (2016-2021)
7.4.2 Europe Pharmaceutical Contract Manufacturing and Contract Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Pharmaceutical Contract Manufacturing and Contract Market Size (2016-2027)
8.2 Asia-Pacific Pharmaceutical Contract Manufacturing and Contract Market Size by Type
8.2.1 Asia-Pacific Pharmaceutical Contract Manufacturing and Contract Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Pharmaceutical Contract Manufacturing and Contract Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Pharmaceutical Contract Manufacturing and Contract Market Size by Type (2016-2027)
8.3 Asia-Pacific Pharmaceutical Contract Manufacturing and Contract Market Size by Application
8.3.1 Asia-Pacific Pharmaceutical Contract Manufacturing and Contract Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Pharmaceutical Contract Manufacturing and Contract Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Pharmaceutical Contract Manufacturing and Contract Market Size by Application (2016-2027)
8.4 Asia-Pacific Pharmaceutical Contract Manufacturing and Contract Market Size by Region
8.4.1 Asia-Pacific Pharmaceutical Contract Manufacturing and Contract Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Pharmaceutical Contract Manufacturing and Contract Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Pharmaceutical Contract Manufacturing and Contract Market Size (2016-2027)
9.2 Latin America Pharmaceutical Contract Manufacturing and Contract Market Size by Type
9.2.1 Latin America Pharmaceutical Contract Manufacturing and Contract Market Size by Type (2016-2021)
9.2.2 Latin America Pharmaceutical Contract Manufacturing and Contract Market Size by Type (2022-2027)
9.2.3 Latin America Pharmaceutical Contract Manufacturing and Contract Market Size by Type (2016-2027)
9.3 Latin America Pharmaceutical Contract Manufacturing and Contract Market Size by Application
9.3.1 Latin America Pharmaceutical Contract Manufacturing and Contract Market Size by Application (2016-2021)
9.3.2 Latin America Pharmaceutical Contract Manufacturing and Contract Market Size by Application (2022-2027)
9.3.3 Latin America Pharmaceutical Contract Manufacturing and Contract Market Size by Application (2016-2027)
9.4 Latin America Pharmaceutical Contract Manufacturing and Contract Market Size by Country
9.4.1 Latin America Pharmaceutical Contract Manufacturing and Contract Market Size by Country (2016-2021)
9.4.2 Latin America Pharmaceutical Contract Manufacturing and Contract Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharmaceutical Contract Manufacturing and Contract Market Size (2016-2027)
10.2 Middle East & Africa Pharmaceutical Contract Manufacturing and Contract Market Size by Type
10.2.1 Middle East & Africa Pharmaceutical Contract Manufacturing and Contract Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Pharmaceutical Contract Manufacturing and Contract Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Pharmaceutical Contract Manufacturing and Contract Market Size by Type (2016-2027)
10.3 Middle East & Africa Pharmaceutical Contract Manufacturing and Contract Market Size by Application
10.3.1 Middle East & Africa Pharmaceutical Contract Manufacturing and Contract Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Pharmaceutical Contract Manufacturing and Contract Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Pharmaceutical Contract Manufacturing and Contract Market Size by Application (2016-2027)
10.4 Middle East & Africa Pharmaceutical Contract Manufacturing and Contract Market Size by Country
10.4.1 Middle East & Africa Pharmaceutical Contract Manufacturing and Contract Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Pharmaceutical Contract Manufacturing and Contract Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Catalent
11.1.1 Catalent Company Details
11.1.2 Catalent Business Overview
11.1.3 Catalent Pharmaceutical Contract Manufacturing and Contract Introduction
11.1.4 Catalent Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2016-2021)
11.1.5 Catalent Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Pharmaceutical Contract Manufacturing and Contract Introduction
11.2.4 Thermo Fisher Scientific Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2016-2021)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Lonza
11.3.1 Lonza Company Details
11.3.2 Lonza Business Overview
11.3.3 Lonza Pharmaceutical Contract Manufacturing and Contract Introduction
11.3.4 Lonza Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2016-2021)
11.3.5 Lonza Recent Development
11.4 Boehringer Ingelheim
11.4.1 Boehringer Ingelheim Company Details
11.4.2 Boehringer Ingelheim Business Overview
11.4.3 Boehringer Ingelheim Pharmaceutical Contract Manufacturing and Contract Introduction
11.4.4 Boehringer Ingelheim Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2016-2021)
11.4.5 Boehringer Ingelheim Recent Development
11.5 Fareva
11.5.1 Fareva Company Details
11.5.2 Fareva Business Overview
11.5.3 Fareva Pharmaceutical Contract Manufacturing and Contract Introduction
11.5.4 Fareva Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2016-2021)
11.5.5 Fareva Recent Development
11.6 Recipharm
11.6.1 Recipharm Company Details
11.6.2 Recipharm Business Overview
11.6.3 Recipharm Pharmaceutical Contract Manufacturing and Contract Introduction
11.6.4 Recipharm Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2016-2021)
11.6.5 Recipharm Recent Development
11.7 Aenova
11.7.1 Aenova Company Details
11.7.2 Aenova Business Overview
11.7.3 Aenova Pharmaceutical Contract Manufacturing and Contract Introduction
11.7.4 Aenova Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2016-2021)
11.7.5 Aenova Recent Development
11.8 AbbVie
11.8.1 AbbVie Company Details
11.8.2 AbbVie Business Overview
11.8.3 AbbVie Pharmaceutical Contract Manufacturing and Contract Introduction
11.8.4 AbbVie Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2016-2021)
11.8.5 AbbVie Recent Development
11.9 Baxter
11.9.1 Baxter Company Details
11.9.2 Baxter Business Overview
11.9.3 Baxter Pharmaceutical Contract Manufacturing and Contract Introduction
11.9.4 Baxter Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2016-2021)
11.9.5 Baxter Recent Development
11.10 Nipro Corp
11.10.1 Nipro Corp Company Details
11.10.2 Nipro Corp Business Overview
11.10.3 Nipro Corp Pharmaceutical Contract Manufacturing and Contract Introduction
11.10.4 Nipro Corp Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2016-2021)
11.10.5 Nipro Corp Recent Development
11.11 Sopharma
11.11.1 Sopharma Company Details
11.11.2 Sopharma Business Overview
11.11.3 Sopharma Pharmaceutical Contract Manufacturing and Contract Introduction
11.11.4 Sopharma Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2016-2021)
11.11.5 Sopharma Recent Development
11.12 Famar
11.12.1 Famar Company Details
11.12.2 Famar Business Overview
11.12.3 Famar Pharmaceutical Contract Manufacturing and Contract Introduction
11.12.4 Famar Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2016-2021)
11.12.5 Famar Recent Development
11.13 Vetter
11.13.1 Vetter Company Details
11.13.2 Vetter Business Overview
11.13.3 Vetter Pharmaceutical Contract Manufacturing and Contract Introduction
11.13.4 Vetter Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2016-2021)
11.13.5 Vetter Recent Development
11.14 Shandong Xinhua
11.14.1 Shandong Xinhua Company Details
11.14.2 Shandong Xinhua Business Overview
11.14.3 Shandong Xinhua Pharmaceutical Contract Manufacturing and Contract Introduction
11.14.4 Shandong Xinhua Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2016-2021)
11.14.5 Shandong Xinhua Recent Development
11.15 Piramal
11.15.1 Piramal Company Details
11.15.2 Piramal Business Overview
11.15.3 Piramal Pharmaceutical Contract Manufacturing and Contract Introduction
11.15.4 Piramal Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2016-2021)
11.15.5 Piramal Recent Development
11.16 Mylan
11.16.1 Mylan Company Details
11.16.2 Mylan Business Overview
11.16.3 Mylan Pharmaceutical Contract Manufacturing and Contract Introduction
11.16.4 Mylan Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2016-2021)
11.16.5 Mylan Recent Development
11.17 Dr. Reddy's
11.17.1 Dr. Reddy's Company Details
11.17.2 Dr. Reddy's Business Overview
11.17.3 Dr. Reddy's Pharmaceutical Contract Manufacturing and Contract Introduction
11.17.4 Dr. Reddy's Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2016-2021)
11.17.5 Dr. Reddy's Recent Development
11.18 Zhejiang Hisun
11.18.1 Zhejiang Hisun Company Details
11.18.2 Zhejiang Hisun Business Overview
11.18.3 Zhejiang Hisun Pharmaceutical Contract Manufacturing and Contract Introduction
11.18.4 Zhejiang Hisun Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2016-2021)
11.18.5 Zhejiang Hisun Recent Development
11.18 Zhejiang Huahai
.1 Zhejiang Huahai Company Details
.2 Zhejiang Huahai Business Overview
.3 Zhejiang Huahai Pharmaceutical Contract Manufacturing and Contract Introduction
.4 Zhejiang Huahai Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2016-2021)
.5 Zhejiang Huahai Recent Development
11.20 Jubilant
11.20.1 Jubilant Company Details
11.20.2 Jubilant Business Overview
11.20.3 Jubilant Pharmaceutical Contract Manufacturing and Contract Introduction
11.20.4 Jubilant Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2016-2021)
11.20.5 Jubilant Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Pharmaceutical Contract Manufacturing and Contract Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Oral
Table 3. Key Players of Injectable
Table 4. Key Players of API
Table 5. Key Players of Other
Table 6. Global Pharmaceutical Contract Manufacturing and Contract Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Pharmaceutical Contract Manufacturing and Contract Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Pharmaceutical Contract Manufacturing and Contract Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Pharmaceutical Contract Manufacturing and Contract Market Share by Regions (2016-2021)
Table 10. Global Pharmaceutical Contract Manufacturing and Contract Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Pharmaceutical Contract Manufacturing and Contract Market Share by Regions (2022-2027)
Table 12. Pharmaceutical Contract Manufacturing and Contract Market Trends
Table 13. Pharmaceutical Contract Manufacturing and Contract Market Drivers
Table 14. Pharmaceutical Contract Manufacturing and Contract Market Challenges
Table 15. Pharmaceutical Contract Manufacturing and Contract Market Restraints
Table 16. Global Pharmaceutical Contract Manufacturing and Contract Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Pharmaceutical Contract Manufacturing and Contract Market Share by Players (2016-2021)
Table 18. Global Top Pharmaceutical Contract Manufacturing and Contract Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmaceutical Contract Manufacturing and Contract as of 2020)
Table 19. Ranking of Global Top Pharmaceutical Contract Manufacturing and Contract Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Pharmaceutical Contract Manufacturing and Contract Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Pharmaceutical Contract Manufacturing and Contract Product Solution and Service
Table 23. Date of Enter into Pharmaceutical Contract Manufacturing and Contract Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Pharmaceutical Contract Manufacturing and Contract Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Pharmaceutical Contract Manufacturing and Contract Revenue Market Share by Type (2016-2021)
Table 27. Global Pharmaceutical Contract Manufacturing and Contract Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Pharmaceutical Contract Manufacturing and Contract Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Pharmaceutical Contract Manufacturing and Contract Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Pharmaceutical Contract Manufacturing and Contract Revenue Market Share by Application (2016-2021)
Table 31. Global Pharmaceutical Contract Manufacturing and Contract Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Pharmaceutical Contract Manufacturing and Contract Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Pharmaceutical Contract Manufacturing and Contract Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Pharmaceutical Contract Manufacturing and Contract Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Pharmaceutical Contract Manufacturing and Contract Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Pharmaceutical Contract Manufacturing and Contract Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Pharmaceutical Contract Manufacturing and Contract Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Pharmaceutical Contract Manufacturing and Contract Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Pharmaceutical Contract Manufacturing and Contract Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Pharmaceutical Contract Manufacturing and Contract Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Pharmaceutical Contract Manufacturing and Contract Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Pharmaceutical Contract Manufacturing and Contract Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Pharmaceutical Contract Manufacturing and Contract Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Pharmaceutical Contract Manufacturing and Contract Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Pharmaceutical Contract Manufacturing and Contract Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Pharmaceutical Contract Manufacturing and Contract Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Pharmaceutical Contract Manufacturing and Contract Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Pharmaceutical Contract Manufacturing and Contract Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Pharmaceutical Contract Manufacturing and Contract Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Pharmaceutical Contract Manufacturing and Contract Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Pharmaceutical Contract Manufacturing and Contract Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Pharmaceutical Contract Manufacturing and Contract Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Pharmaceutical Contract Manufacturing and Contract Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Pharmaceutical Contract Manufacturing and Contract Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Pharmaceutical Contract Manufacturing and Contract Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Pharmaceutical Contract Manufacturing and Contract Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Pharmaceutical Contract Manufacturing and Contract Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Pharmaceutical Contract Manufacturing and Contract Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Pharmaceutical Contract Manufacturing and Contract Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Pharmaceutical Contract Manufacturing and Contract Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Pharmaceutical Contract Manufacturing and Contract Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Pharmaceutical Contract Manufacturing and Contract Market Size by Country (2022-2027) & (US$ Million)
Table 63. Catalent Company Details
Table 64. Catalent Business Overview
Table 65. Catalent Pharmaceutical Contract Manufacturing and Contract Product
Table 66. Catalent Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2016-2021) & (US$ Million)
Table 67. Catalent Recent Development
Table 68. Thermo Fisher Scientific Company Details
Table 69. Thermo Fisher Scientific Business Overview
Table 70. Thermo Fisher Scientific Pharmaceutical Contract Manufacturing and Contract Product
Table 71. Thermo Fisher Scientific Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2016-2021) & (US$ Million)
Table 72. Thermo Fisher Scientific Recent Development
Table 73. Lonza Company Details
Table 74. Lonza Business Overview
Table 75. Lonza Pharmaceutical Contract Manufacturing and Contract Product
Table 76. Lonza Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2016-2021) & (US$ Million)
Table 77. Lonza Recent Development
Table 78. Boehringer Ingelheim Company Details
Table 79. Boehringer Ingelheim Business Overview
Table 80. Boehringer Ingelheim Pharmaceutical Contract Manufacturing and Contract Product
Table 81. Boehringer Ingelheim Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2016-2021) & (US$ Million)
Table 82. Boehringer Ingelheim Recent Development
Table 83. Fareva Company Details
Table 84. Fareva Business Overview
Table 85. Fareva Pharmaceutical Contract Manufacturing and Contract Product
Table 86. Fareva Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2016-2021) & (US$ Million)
Table 87. Fareva Recent Development
Table 88. Recipharm Company Details
Table 89. Recipharm Business Overview
Table 90. Recipharm Pharmaceutical Contract Manufacturing and Contract Product
Table 91. Recipharm Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2016-2021) & (US$ Million)
Table 92. Recipharm Recent Development
Table 93. Aenova Company Details
Table 94. Aenova Business Overview
Table 95. Aenova Pharmaceutical Contract Manufacturing and Contract Product
Table 96. Aenova Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2016-2021) & (US$ Million)
Table 97. Aenova Recent Development
Table 98. AbbVie Company Details
Table 99. AbbVie Business Overview
Table 100. AbbVie Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2016-2021) & (US$ Million)
Table 101. AbbVie Recent Development
Table 102. Baxter Company Details
Table 103. Baxter Business Overview
Table 104. Baxter Pharmaceutical Contract Manufacturing and Contract Product
Table 105. Baxter Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2016-2021) & (US$ Million)
Table 106. Baxter Recent Development
Table 107. Nipro Corp Company Details
Table 108. Nipro Corp Business Overview
Table 109. Nipro Corp Pharmaceutical Contract Manufacturing and Contract Product
Table 110. Nipro Corp Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2016-2021) & (US$ Million)
Table 111. Nipro Corp Recent Development
Table 112. Sopharma Company Details
Table 113. Sopharma Business Overview
Table 114. Sopharma Pharmaceutical Contract Manufacturing and Contract Product
Table 115. Sopharma Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2016-2021) & (US$ Million)
Table 116. Sopharma Recent Development
Table 117. Famar Company Details
Table 118. Famar Business Overview
Table 119. Famar Pharmaceutical Contract Manufacturing and Contract Product
Table 120. Famar Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2016-2021) & (US$ Million)
Table 121. Famar Recent Development
Table 122. Vetter Company Details
Table 123. Vetter Business Overview
Table 124. Vetter Pharmaceutical Contract Manufacturing and Contract Product
Table 125. Vetter Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2016-2021) & (US$ Million)
Table 126. Vetter Recent Development
Table 127. Shandong Xinhua Company Details
Table 128. Shandong Xinhua Business Overview
Table 129. Shandong Xinhua Pharmaceutical Contract Manufacturing and Contract Product
Table 130. Shandong Xinhua Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2016-2021) & (US$ Million)
Table 131. Shandong Xinhua Recent Development
Table 132. Piramal Company Details
Table 133. Piramal Business Overview
Table 134. Piramal Pharmaceutical Contract Manufacturing and Contract Product
Table 135. Piramal Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2016-2021) & (US$ Million)
Table 136. Piramal Recent Development
Table 137. Mylan Company Details
Table 138. Mylan Business Overview
Table 139. Mylan Pharmaceutical Contract Manufacturing and Contract Product
Table 140. Mylan Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2016-2021) & (US$ Million)
Table 141. Mylan Recent Development
Table 142. Dr. Reddy's Company Details
Table 143. Dr. Reddy's Business Overview
Table 144. Dr. Reddy's Pharmaceutical Contract Manufacturing and Contract Product
Table 145. Dr. Reddy's Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2016-2021) & (US$ Million)
Table 146. Dr. Reddy's Recent Development
Table 147. Zhejiang Hisun Company Details
Table 148. Zhejiang Hisun Business Overview
Table 149. Zhejiang Hisun Pharmaceutical Contract Manufacturing and Contract Product
Table 150. Zhejiang Hisun Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2016-2021) & (US$ Million)
Table 151. Zhejiang Hisun Recent Development
Table 152. Zhejiang Huahai Company Details
Table 153. Zhejiang Huahai Business Overview
Table 154. Zhejiang Huahai Pharmaceutical Contract Manufacturing and Contract Product
Table 155. Zhejiang Huahai Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2016-2021) & (US$ Million)
Table 156. Zhejiang Huahai Recent Development
Table 157. Jubilant Company Details
Table 158. Jubilant Business Overview
Table 159. Jubilant Pharmaceutical Contract Manufacturing and Contract Product
Table 160. Jubilant Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2016-2021) & (US$ Million)
Table 161. Jubilant Recent Development
Table 162. Research Programs/Design for This Report
Table 163. Key Data Information from Secondary Sources
Table 164. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pharmaceutical Contract Manufacturing and Contract Market Share by Type: 2020 VS 2027
Figure 2. Oral Features
Figure 3. Injectable Features
Figure 4. API Features
Figure 5. Other Features
Figure 6. Global Pharmaceutical Contract Manufacturing and Contract Market Share by Application: 2020 VS 2027
Figure 7. Small Medium Enterprise Case Studies
Figure 8. Large Enterprise Case Studies
Figure 9. Pharmaceutical Contract Manufacturing and Contract Report Years Considered
Figure 10. Global Pharmaceutical Contract Manufacturing and Contract Market S
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs